Reporting owner

Chevallard Daniel R.

Reporting owner CIK 0001706176 · Chief Financial Officer

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

2 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table

Transaction date	Company / security	Reporting owners	Acquisition type
Nov 7, 2025	LENZ Therapeutics, Inc.Common Stock	Chevallard Daniel R.	Purchase
Nov 7, 2025	LENZ Therapeutics, Inc.Common Stock	Chevallard Daniel R.	Purchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transacted	Company	Reporting owners	Type / security	Quantity	Price / reference value	Details
Nov 7, 2025Trade: Nov 7, 2025	LENZ Therapeutics, Inc.LENZ · company listings	Chevallard Daniel R.Chief Financial Officer	PurchaseCommon StockNon-derivative security · Code P	2,178	22.7561Value: 49,562.7858Currency not specified	View ↗
Nov 7, 2025Trade: Nov 7, 2025	LENZ Therapeutics, Inc.LENZ · company listings	Chevallard Daniel R.Chief Financial Officer	PurchaseCommon StockNon-derivative security · Code P	20	22.71Value: 454.2Currency not specified	View ↗

2 transactions on this page. Filing date, newest first.